< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 78
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project
- Discovery of (pan)-henipavirus antivirals using novel in vitro and in vivo Cedar virus modelsFrom21 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
- Vaccine-mediated protection among filoviruses induced by experimental yellow fever 17D-vectored vaccine candidatesFrom15 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GUT VIrus BRain Axis Technology In OrgaNoid ScienceFrom1 Apr 2021 → TodayFunding: H2020 - Leadership in enabling and industrial technologies (LEIT)
- Towards a thermostable dual yellow fever/Lassa fever virus vaccine and therapeutic strategies against the Lassa and related mammarenaviruses.From1 Nov 2020 → 31 Oct 2022Funding: FWO junior postdoctoral fellowship
- MIRACLE: autonomous microfluidic patch for plasmid-based vaccineFrom1 Oct 2020 → TodayFunding: BOF - projects
Publications
1 - 10 of 597
- Moral-oids: An Ethical Exploration of Organoid Models in Biomedical Research(2023)
Authors: Andrew Barnhart, Kris Dierickx, Johan Neyts
- Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies(2023)
Authors: Lotte Coelmont, Johan Neyts, Suzanne Kaptein
- YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge(2023)
Authors: Viktor Lemmens, Lara Kelchtermans, Hendrik Jan Thibaut, Johan Neyts, Kai Henrik Dallmeier
- Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors(2023)
Authors: Suzanne Kaptein, Johan Neyts
Pages: 8808 - 8821 - Antiviral strategies for epidemic and pandemic preparedness(2023)
Authors: Dirk Jochmans, Manon Laporte, Johan Neyts
Pages: 856 - 860 - Author Correction: Reverse engineering synthetic antiviral amyloids.(2023)
Authors: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
Pages: 3492 - Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks(2023)
Authors: Lize Cuypers, Samuel Hong, Sarah Gorissen, Bert Vanmechelen, Pieter Vermeersch, Katrien Lagrou, Marc Van Ranst, Johan Neyts, Guy Baele, Piet Maes, et al.
Pages: 722 - + - Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters(2023)
Authors: Rana Abdelnabi, Dirk Jochmans, Birgit Weynand, Johan Neyts
- Urtica dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model(2023)
Authors: Lisanne Terrie, Lieven Thorrez, Dirk Jochmans, Johan Neyts
- Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment(2023)
Authors: Rana Abdelnabi, Dirk Jochmans, Birgit Weynand, Johan Neyts
Patents
1 - 10 of 10
- Treatment and prevention of dengue disease (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Corona virus binders (Inventor)
- Antiviral 1,3-di-oxo-indene compounds (Inventor)
- Lassavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Coronavirus vaccines (Inventor)
- Antiviral 1,3-di-oxo-indene compounds (Inventor)
- Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- Chimeric flavivirus lyssavirus vaccines (Inventor)